Your browser is no longer supported. Please, upgrade your browser.
BlackRock Health Sciences Trust II
Index- P/E- EPS (ttm)- Insider Own0.01% Shs Outstand- Perf Week0.33%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month1.04%
Income- PEG- EPS next Q- Inst Own11.39% Short Float- Perf Quarter-10.25%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.05 Perf Half Y7.84%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year43.63%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range18.51 - 30.96 Perf YTD-4.92%
Dividend1.74 P/FCF- EPS past 5Y- ROI- 52W High-12.02% Beta-
Dividend %6.39% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low47.16% ATR0.66
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)53.28 Volatility1.92% 2.33%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.86 Prev Close27.12
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume309.05K Price27.24
Recom- SMA203.03% SMA50-1.12% SMA2004.80% Volume264,334 Change0.44%
Nov-30-20 05:00PM  
Mar-02-20 04:30PM  
BlackRock Health Sciences Trust II's (BMEZ) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries. The Trust utilizes an option writing (selling) strategy in an effort to generate current gains from options premiums and to enhance the Trust's risk-adjusted returns.